Monday, 11 May 2015 10:10

Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission

Written by 
Rate this item
(0 votes)

Conclusion of study "cost-effectiveness analysis suggests surveillance imaging of asymptomatic DLBCL patients in remission offers little clinical benefit at substantial economic costs."

Read 204634 times Last modified on Wednesday, 25 January 2017 14:52


Global Database Search

 knowyoursubtype iconb   facebook2 twitter2 youtube1




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

Copyright © 2017 Lymphoma Coalition. All rights reserved.